This retrospective cross-sectional study was performed in accordance with the tenets outlined in the Declaration of Helsinki and approved by the Institutional Review Board of Yonsei University (4-2020-0592). The requirement for informed consent was waived due to the retrospective nature of the study. We reviewed the medical records of all patients treated at Severance Hospital from January 2017 to July 2020.
A total of 109 healthy controls and 103 patients with NTG were included in this study. All participants underwent ophthalmologic examinations. All the examinations were carried out as usual for glaucoma patients, or patients who visited our hospital suspected of glaucoma. These included slit-lamp biomicroscopy, Goldmann applanation tonometry, gonioscopy, dilated fundus examination, measurement of best-corrected visual acuity (BCVA), and measurement of axial length (AXL) (IOL Master; Carl Zeiss Meditec, Dublin, CA, USA). Spectral-domain optical coherence tomography (OCT) (Cirrus HD-OCT, software v11.0; Carl Zeiss Meditec) and standard automated perimetry (Humphrey Field Analyzer II; Carl Zeiss Meditec) were performed to evaluate glaucomatous changes. PWV was usually measured at health check-ups, and blood tests included hemoglobin A1c (HbA1c), total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, estimated glomerular filtration rate (eGFR), and uric acid. The interval between glaucoma examination and PWV measurements did not exceed six months.
Inclusion criteria were as follows: (1) age ≥ 40 years; (2) able to confirm open angle on medical records; (3) BCVA ≥ 20/40; and (4) refractive error between +3 and –6 diopters (D) spherical and ±3 D cylindrical. NTG was diagnosed when the maximum untreated IOP was < 21 mm Hg on three repeated measurements obtained at different times on separate follow-up visits and in the presence of glaucomatous optic discs (neuroretinal rim thinning and excavation), peripapillary retinal nerve fiber layer (RNFL) defect, and glaucomatous visual field (VF) defects. Glaucomatous VF defects were defined if a cluster of at least three contiguous points had
P < 0.05 on the pattern standard deviation plot where at least one of these points had
P < 0.01, or if glaucoma hemifield test was outside normal limits.
25 Glaucoma severity stage was based on the Hodapp-Parrish-Anderson criteria.
26 The medical records were re-evaluated by two glaucoma specialists (T.L. and H.Y.B.). If the two specialists could not agree on a diagnosis of NTG, the final decision was made by a third glaucoma specialist (S.Y.L.). Healthy controls did not have glaucomatous optic discs or VF defects and exhibited normal RNFL thickness, which was within 95% of the internally set database for OCT results.
Patients with poor data quality or other ocular comorbidities were excluded: (1) signal strength less than 7, images with artifacts; (2) eyes with a diagnosis of pigment dispersion glaucoma, pseudoexfoliative glaucoma, or primary angle-closure glaucoma; (3) retinal disorder (diabetic retinopathy, age-related macular degeneration, retinal detachment, etc.); (4) history of ocular trauma or intraocular surgery; (5) history of brain disorder (brain hemorrhage, brain infarction, brain aneurysm, brain tumor, etc.); and (6) history of optic nerve disorder (optic neuritis, ischemic optic neuropathy, optic coloboma, etc.).
For patients with NTG, the eye with a more severe glaucoma status was chosen as the study eye. If patients had a similar glaucoma severity in both eyes, the study eye was randomly selected. For patients with healthy eyes, the study eye was also randomly selected.